SAN FRANCISCO, Jan 13 (Reuters) - AstraZeneca has agreed to buy Boston-based Modella AI, the companies said on Tuesday, as the drug industry increases its use of artificial intelligence to accelerate the discovery of new drugs.
The companies did not disclose financial terms. In a press release, Modella AI said its "foundation models" and AI agents would be integrated into oncology research and development to support clinical development and biomarker discovery.
"Oncology drug development is becoming more complex, more data-rich and more time-sensitive," said Gabi Raia, Modella AI's chief commercial officer, adding that joining AstraZeneca would allow it to deploy its tools in global trials and clinical settings.
AstraZeneca said that this was the first acquisition of an AI firm by a big pharmaceutical company.
In an interview at the JP Morgan Healthcare Conference, AstraZeneca Chief Financial Officer Aradhana Sarin said the acquisition would "supercharge" the company's quantitative pathology and biomarker discovery efforts by bringing more data and AI capabilities in-house.
The deal was one of a number of pacts between major drug firms and AI companies that were unveiled at the healthcare conference, including a $1 billion collaboration between Nvidia and Eli Lilly. They plan to build a new research lab using Nvidia's latest-generation AI chips.
Modella will accelerate AstraZeneca’s efforts to make pathology more quantitative - using computers to analyze biopsies for relevant proteins and correlate them with clinical data - so AstraZeneca can develop “highly targeted biomarkers and then highly targeted therapeutics,” Sarin said.
The deal is an expansion of a multi-year collaboration that the companies unveiled in July.
Sarin said that partnership served as a "test drive," adding that AstraZeneca ultimately wanted Modella's data, foundation models and AI talent in-house.
She said AI tools could be used to more rapidly select patients for drug trials, which could increase the odds of clinical success and cut related costs.
(Reporting by Maggie Fick; Editing by Thomas Derpinghaus)
LATEST POSTS
- 1
Damaged Shenzhou-20 spacecraft to return to Earth uncrewed for inspection01.12.2025 - 2The most effective method to Distinguish the Best Material Organization in Your Space17.10.2023
- 3Dominating Your Cash: The Fundamental Manual for Overseeing Individual accounting records06.07.2023
- 4More than 800 flights canceled as FAA cuts traffic at 40 major airports. Here's what to know.07.11.2025
- 5The Best Internet Mastering Stages for Expertise Improvement06.07.2023
- Ads promising cosmetic surgery patients a ‘dream body’ with minimal risk get little scrutiny
- Italy's Beloved Trevi Fountain Hides A Unique Secret That Can Be Explored Underground
- Six Flags Opens the Tallest, Fastest and Longest Roller Coaster in the World
- Ghassan Al-Duhaini to replace Abu Shabab as Popular Forces leader in Gaza
- Ukraine demands army of 800,000 under peace plan
- Hot peppers sent him to the ER. Two years later, a ‘ghost bill’ arrived.
- 6 Fun Urban areas For Seniors To Travel
- She's been a Bond girl and a mutant. Now she's grappling with Hollywood's obsession with 'eternal youth.'
- 4 Electric Vehicle Brands: Execution, Unwavering quality, and Development
